Compare NVCR & HCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVCR | HCI |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2015 | 2008 |
| Metric | NVCR | HCI |
|---|---|---|
| Price | $16.59 | $186.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $28.08 | ★ $230.00 |
| AVG Volume (30 Days) | ★ 968.8K | 101.1K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | 21.79 | ★ 155.57 |
| EPS | N/A | ★ 11.05 |
| Revenue | $655,353,000.00 | ★ $900,946,000.00 |
| Revenue This Year | $7.72 | $11.44 |
| Revenue Next Year | $6.74 | $7.67 |
| P/E Ratio | ★ N/A | $16.99 |
| Revenue Growth | 8.28 | ★ 20.12 |
| 52 Week Low | $9.82 | $144.75 |
| 52 Week High | $21.45 | $210.50 |
| Indicator | NVCR | HCI |
|---|---|---|
| Relative Strength Index (RSI) | 49.68 | 55.04 |
| Support Level | $16.33 | $181.79 |
| Resistance Level | $18.43 | $196.37 |
| Average True Range (ATR) | 0.75 | 3.82 |
| MACD | -0.07 | -0.24 |
| Stochastic Oscillator | 46.42 | 41.87 |
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.